Since targeting PI3K, AKT, mTORC1, or mTORC2 sites are reported to induce feedback activation of some survival signalings6,8,34, cancer cells can escape from single drug treatment, which only targeting PI3K/AKT. The gene discussed is AKT1; the disease is cancer.